Table 1 Baseline characteristics
From: Tracking dyspnea up to supplemental oxygen prescription among patients with pulmonary fibrosis
Prescribed O2 N = 28 | Not Prescribed O2 N = 166 | P value | |
|---|---|---|---|
Female | 10 (36) | 83 (50) | 0.15 |
Age, yrs | 67.5 ± 7.9 | 67.9 ± 9.6 | 0.99 |
Smoking | |||
Current | 1 (4) | 2 (1) | |
Former | 15 (54) | 86 (52) | |
Never | 12 (43) | 78 (47) | 0.61 |
State of residence | |||
Colorado | 4 (14) | 67 (41) | |
New Mexico | 1 (4) | 12 (7) | |
Texas | 3 (11) | 12 (7) | |
Other | 20 (71) | 75 (45) | 0.03 |
Pulmonary fibrosis | |||
IPF | 20 (71) | 41 (25) | |
CTD | 4 (14) | 62 (37) | |
cHP | 2 (7) | 14 (8) | |
FPF | 1 (4) | 11 (7) | |
Other | 1 (11) | 38 (23) | < 0.0001 |
Surgical biopsy | 11 (39) | 59 (36) | 0.61 |
FVC% | 67.3 ± 17.5 | 77.81 ± 30.3a | 0.008 |
DLCO% | 52.5 ± 12.9 | 64.3 ± 15.4b | 0.0016 |
Enrollment UCSD score | 38.4 ± 19.6 | 22.6 ± 18.7 | < 0.0001 |
Duration of follow-up, days | 270.1 ± 201.5 | 473.6 ± 191.5 | < 0.0001 |